CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The REBELLION project focuses on developing light-responsive molecular nanomachines to combat antimicrobial resistance. By targeting bacterial pathogens with minimal harm to human cells, it aims to create a new class of antimicrobials that enhances treatment efficacy and reduces resistance development.
Antimicrobial resistance (AMR) has been identified as a major threat to mankind in the 21st century.
Thus, there is a critical need to develop new antimicrobials and new delivery strategies to preserve the viability of the existing antibiotics.
One such strategy is the use of molecular nanomachines (MNMs) for targeted and controlled inactivation of bacterial pathogens. REBELLION aims to develop new light responsive MNMs against bacterial pathogens with minimal damage to mammalian tissues.
This s…
FOUNDATION HEALTH RESEARCH INSTITUTE OF THE BALEARIC ISLANDS
FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA ILLES BALEARS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Pepperell Ma
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
